| 117 | SEARCHING FOR NOVEL DRUGS IN MYOTONIA CONGENITA: EVALUATION OF ANTHRACENE-9-CARBOXYLIC ACID AND NIFLUMIC ACID BINDING SITES AND CHAPERONE ACTIVITY ON CLC-1 CHLORIDE CHANNEL MUTANTS.
1)Altamura C. 2)Imbrici P. 3)Sahbani D. 4)Toscano A. 5)Mantegazza R. 6)Lo Monaco M. 7)Mangiatordi G.F. 8)Nicolotti O. 9) Carratù M.R. 10)Desaphy J.F. 11)Conte Camerino D. |
| 202 | SKELETAL MUSCLE CLC-1 CHANNEL: FROM GENE TO PROTEIN, FROM BIRTH TO AGING TOWARD A PERSONALIZED MEDICINE
1)Conte E. 2)Fonzino A. 3)Cibelli A. 4)De luca A. 5)Pierno S. 6)Nicchia GP. 7)Camerino GM. |
| 249 | DEVELOPMENT OF NEW BENZOTHIAZOLAMINES TO ENHANCE USE-DEPENDENT INHIBITION OF VOLTAGE-GATED SODIUM CHANNELS.
1)Farinato A. 2)Altamura C. 3)Cavaluzzi MM. 4)Lentini G. 5)Carratù MR. 6)Conte camerino D. 7)Desaphy JF. |
| 302 | BARTTER'S SYNDROME AND KIDNEY CLC-K CHANNELS: A PHARMACOVIGILANCE-BASED DRUG DISCOVERY STRATEGY TO REPROFILE SARTANS AS NOVEL LIGANDS
1)Imbrici P. 2)Tricarico D. 3)Mangiatordi GF. 4)Nicolotti O. 5)Conte D. 6)Liantonio A. |
| 309 | FUNCTIONAL COMPARISON AMONG THREE VARIANTS AFFECTING THE SAME CRITICAL RESIDUE IN THE Kv7.2 POTASSIUM CHANNEL GENE IDENTIFIED IN PATIENTS WITH EPILEPSY AND/OR SEVERE DEVELOPMENTAL IMPAIRMENT
1)Lauritano A. 2)Miceli F. 3)Cimino M. 4)Onore ME. 5)Nappi P. 6)Weckhuysen S. 7)Cooper EC. 8)Taglialatela M. |
| 327 | STARGAZIN REGULATES THE BIOCHEMICAL AND FUNCTIONAL PROPERTIES OF Kv7.2 VOLTAGE-GATED POTASSIUM CHANNELS
1)Manocchio L. 2)Soldovieri MV. 3)Ambrosino P. 4)Mosca I. 5)Caldeira G. 6)Rodrigues M. 7)Carvalho AL. 8)Taglialatela M. |
| 352 | Compound heterozygosis in the kcnq3 gene in a patient with early-onset Epileptic Encephalopathy (EOEE)
1)Mosca I.. 2)Soldovieri MV. 3)Ambrosino P.. 4)Freri E.. 5)Castellotti B.. 6)Gellera C.. 7)Difrancesco JC. 8)Taglialatela M.. |
| 400 | Understanding the pathogenesis of oxaliplatin-induced peripheral neurotoxicity
1)Riva BR. 2)Potenzieri AP. 3)Lim DL. 4)Dionisi MD. 5)Carozzi CV. 6)Distasi CD. 7)Genazzani AG. |
